JP2016521760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521760A5 JP2016521760A5 JP2016520399A JP2016520399A JP2016521760A5 JP 2016521760 A5 JP2016521760 A5 JP 2016521760A5 JP 2016520399 A JP2016520399 A JP 2016520399A JP 2016520399 A JP2016520399 A JP 2016520399A JP 2016521760 A5 JP2016521760 A5 JP 2016521760A5
- Authority
- JP
- Japan
- Prior art keywords
- chloro
- fluoro
- phenyl
- day
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 4-chloro-2-fluorophenyl Chemical group 0.000 claims 21
- 239000003814 drug Substances 0.000 claims 21
- 229940126062 Compound A Drugs 0.000 claims 11
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 10
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 10
- 229960004117 capecitabine Drugs 0.000 claims 10
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 9
- 229960001756 oxaliplatin Drugs 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 8
- TVTXCJFHQKSQQM-LJQIRTBHSA-N 4-[[(2r,3s,4r,5s)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1NC(=O)[C@H]1[C@H](C=2C(=C(Cl)C=CC=2)F)[C@@](C#N)(C=2C(=CC(Cl)=CC=2)F)[C@H](CC(C)(C)C)N1 TVTXCJFHQKSQQM-LJQIRTBHSA-N 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 239000005711 Benzoic acid Substances 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 235000010233 benzoic acid Nutrition 0.000 claims 2
- 230000003203 everyday effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- ZSTCHQOKNUXHLZ-PIRIXANTSA-L [(1r,2r)-2-azanidylcyclohexyl]azanide;oxalate;pentyl n-[1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate;platinum(4+) Chemical compound [Pt+4].[O-]C(=O)C([O-])=O.[NH-][C@@H]1CCCC[C@H]1[NH-].C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 ZSTCHQOKNUXHLZ-PIRIXANTSA-L 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361836899P | 2013-06-19 | 2013-06-19 | |
| US61/836,899 | 2013-06-19 | ||
| PCT/EP2014/062496 WO2014202497A1 (en) | 2013-06-19 | 2014-06-16 | Combination of ro5503781, capecitabine and oxaliplantin for cancer therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521760A JP2016521760A (ja) | 2016-07-25 |
| JP2016521760A5 true JP2016521760A5 (enExample) | 2017-03-09 |
| JP6549107B2 JP6549107B2 (ja) | 2019-07-24 |
Family
ID=50976625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016520399A Expired - Fee Related JP6549107B2 (ja) | 2013-06-19 | 2014-06-16 | がんの処置のための、ro5503781、カペシタビン及びオキサリプラチンの組み合わせ |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160129034A1 (enExample) |
| EP (1) | EP3010508B1 (enExample) |
| JP (1) | JP6549107B2 (enExample) |
| KR (1) | KR20160009677A (enExample) |
| CN (1) | CN105263499B (enExample) |
| BR (1) | BR112015030734A2 (enExample) |
| CA (1) | CA2912743A1 (enExample) |
| ES (1) | ES2747073T3 (enExample) |
| MX (1) | MX2015017124A (enExample) |
| PL (1) | PL3010508T3 (enExample) |
| RU (1) | RU2015152175A (enExample) |
| WO (1) | WO2014202497A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021033144A1 (en) * | 2019-08-20 | 2021-02-25 | Intas Pharmaceuticals Ltd. | Oral suspension of capecitabine |
| CN113698435B (zh) * | 2021-08-25 | 2023-09-29 | 中国人民解放军空军军医大学 | 一类含有p53-MDM2抑制剂的四价铂配合物及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2644643C (en) * | 2006-03-22 | 2015-05-19 | Janssen Pharmaceutica N.V. | Inhibitors of the interaction between mdm2 and p53 |
| SG10202102855RA (en) * | 2008-08-04 | 2021-05-28 | Wyeth Llc | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| US8354444B2 (en) * | 2008-09-18 | 2013-01-15 | Hoffmann-La Roche Inc. | Substituted pyrrolidine-2-carboxamides |
-
2014
- 2014-06-16 MX MX2015017124A patent/MX2015017124A/es unknown
- 2014-06-16 JP JP2016520399A patent/JP6549107B2/ja not_active Expired - Fee Related
- 2014-06-16 WO PCT/EP2014/062496 patent/WO2014202497A1/en not_active Ceased
- 2014-06-16 CA CA2912743A patent/CA2912743A1/en not_active Abandoned
- 2014-06-16 EP EP14731223.5A patent/EP3010508B1/en active Active
- 2014-06-16 CN CN201480032428.2A patent/CN105263499B/zh not_active Expired - Fee Related
- 2014-06-16 US US14/897,416 patent/US20160129034A1/en not_active Abandoned
- 2014-06-16 PL PL14731223T patent/PL3010508T3/pl unknown
- 2014-06-16 RU RU2015152175A patent/RU2015152175A/ru not_active Application Discontinuation
- 2014-06-16 ES ES14731223T patent/ES2747073T3/es active Active
- 2014-06-16 BR BR112015030734A patent/BR112015030734A2/pt not_active IP Right Cessation
- 2014-06-16 KR KR1020157035737A patent/KR20160009677A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018109022A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| JP2014526503A5 (enExample) | ||
| JP2015523397A5 (enExample) | ||
| JP2015536964A5 (enExample) | ||
| JP2011173928A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2016515628A5 (enExample) | ||
| JP2016528162A5 (enExample) | ||
| JP2015529234A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| JP2019515908A5 (enExample) | ||
| JP2019517549A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| JP2012522837A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| JP2016527202A5 (enExample) | ||
| JP2015507020A5 (enExample) | ||
| JP2020515523A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| JP2014148552A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2016521760A5 (enExample) |